Health Management and Economics, School of Public Health, Health Policy and Management Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Health policy Research center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
BMC Health Serv Res. 2023 Sep 25;23(1):1028. doi: 10.1186/s12913-023-10020-w.
Infectious disease outbreaks pose a significant threat to public health, and achieving herd immunity highlights the importance of addressing conflicts of interest (COI) in vaccine development and policy-making. This policy brief aims to present policy options that address COI regarding vaccines in infectious disease outbreaks, based on good governance for health approach.
Our study used a scoping review methodology. We conducted a systematic search, which led to identifying 43 eligible articles. A qualitative approach (i.e., content analysis) was employed for data analysis, using "ATLAS.ti 9" software. The primary results underwent a process of cleaning, categorisation, and subsequent discussion in three sessions with the research team.
Relationships between theindustry and "government/policymakers" as well as "academic institutions/researchers" are prominent origins of COI regarding the vaccine in infectious disease outbreaks. To address this issue, we present nine policy options that target both the root cause of the problem and the adoption of good governance for health approach.
The key principles of good governance for health, including, "Transparency", "The Rule of Law", "Effectiveness", "Efficiency", "Participation", "Consensus Orientation", "Equality", "Responsibility", "Responsiveness" and "Accountability" must be taken into account when formulating policy options to address COI regarding the vaccine in infectious disease outbreaks. The effectiveness of the policy options outlined in this policy brief should be assessed in practical contexts, as this evaluation may uncover the need for revisions.
传染病暴发对公共卫生构成重大威胁,而实现群体免疫则凸显了解决疫苗开发和决策中利益冲突(COI)的重要性。本政策简报旨在根据卫生良好治理方法,提出应对传染病暴发中疫苗相关 COI 的政策选择。
我们采用范围综述方法。我们进行了系统搜索,确定了 43 篇符合条件的文章。使用“ATLAS.ti 9”软件,采用定性方法(即内容分析)进行数据分析。主要结果经过与研究团队的三次会议进行了清理、分类和讨论的过程。
行业与“政府/决策者”以及“学术机构/研究人员”之间的关系是传染病暴发中疫苗相关 COI 的主要来源。为了解决这个问题,我们提出了九个针对问题根源和采用卫生良好治理方法的政策选择。
在制定应对传染病暴发中疫苗相关 COI 的政策选择时,必须考虑卫生良好治理的关键原则,包括“透明度”、“法治”、“有效性”、“效率”、“参与”、“共识导向”、“平等”、“责任”、“响应性”和“问责制”。应在实际情况下评估本政策简报中概述的政策选择的有效性,因为这种评估可能会发现需要修订。